We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NET

News List

Novel radionuclide therapy found to be more effective in NET patients europeanpharmaceuticalreview
March 24, 2021
The study shows modifying the standard of care for late-stage neuroendocrine tumours (NETs) with Evans blue dye makes the treatment more effective and potentially less toxic.
Cartesian Initiates Trial of Cell Therapy for ARDS, COVID-19 americanpharmaceuticalreview
September 02, 2020
Cartesian Therapeutics has initiated a Phase 1/2 clinical trial of its lead RNA-engineered mesenchymal stem cell (MSC) therapy, Descartes-30, in patients with moderate-to-severe acute respiratory distress syndrome (ARDS), including that caused by COVID-19
Aurobindo Pharma net surges 39.5 per cent to Rs 636 crore expresspharma
August 09, 2019
Revenues stood at Rs 5,444.6 crore against Rs 4,250.3 crore and witnessed a strong growth of 28.1 per cent